A Phase IV, Double-blind, Placebo-controlled, Canadian Multicentre Study Comparing Two Treatment Strategies of Dronedarone Administration Following ELECTive caRdioversion for Prevention of Symptomatic Atrial Fibrillation (AF) Recurrence.

Trial Profile

A Phase IV, Double-blind, Placebo-controlled, Canadian Multicentre Study Comparing Two Treatment Strategies of Dronedarone Administration Following ELECTive caRdioversion for Prevention of Symptomatic Atrial Fibrillation (AF) Recurrence.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2014

At a glance

  • Drugs Dronedarone (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms ELECTRA
  • Sponsors Sanofi
  • Most Recent Events

    • 05 Aug 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
    • 07 Mar 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 07 Mar 2012 Actual patient number is 292 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top